For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying opportunity.

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in April, moving ...

Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job ...

BlackRock Health Sciences Opportunities Fund posted returns of 3.66% (Institutional shares) and 3.60% (Investor A shares, ...

Focused on evaluation of strategic alternatives, with restructuring and closure of the Netherlands operationsEnrollment in LAVA-1266 Phase 1 continues to progressCash, cash equivalents and short-term ...

As of March 31, 2025, LAVA had cash, cash equivalents, and short-term investments of $66.6 million, compared to cash, cash equivalents, and short-term investments of $76.6 million as of December 31, ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

FacebookTweetPin AI and growth stocks in general have continued extending their gains so far today after the CPI report ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...